Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cronos Group Inc (TSX: CRON )

3.030 +0.060 (+2.02%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 148,687
Open 2.990
Bid (Size) 3.000 (60)
Ask (Size) 3.060 (25)
Prev. Close 2.970
Today's Range 2.970 - 3.060
52wk Range 2.330 - 4.280
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lord Jones® Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada
From Cronos Group Inc.
Via GlobeNewswire
As Legalization Spreads, Trump Now Says Marijuana Criminalization Is Wrong
Via CannabisNewsWire
Topics Cannabis Government
Exposures Cannabis Political

Performance

YTD
+6.69%
+6.69%
1 Month
-7.34%
-7.34%
3 Month
-12.17%
-12.17%
6 Month
+15.65%
+15.65%
1 Year
+13.48%
+13.48%

More News

Read More
Highest On Record - Cronos Group Reports 46% YoY Increase In Q2 Net Revenue
Via Benzinga
Cronos Group Reports 2024 Second Quarter Results
From Cronos Group Inc.
Via GlobeNewswire
Latest NY Crackdown on Illicit Marijuana Outlets Starting to Stem the Vice
Via CannabisNewsWire
Topics Cannabis Law Enforcement
Exposures Cannabis Legal
420 with CNW — New Study Reports Patients Say Marijuana More Helpful for Musculoskeletal Pain Than Conventional Medications
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Canopy Growth And Other Hot Cannabis Stocks Will Soon Report Earnings, What Investors Need To Know Now
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cronos Group Inc. to Hold 2024 Second Quarter Earnings Conference Call on August 8, 2024
From Cronos Group Inc.
Via GlobeNewswire
Latest Cannabis Hires And Board Changes, Here's What You Need To Know
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cronos Group Inc. Announces Results of Reconvened 2024 Annual Meeting of Shareholders
From Cronos Group Inc.
Via GlobeNewswire
420 with CNW – Advocates Submit Petitions Seeking to Put Adult-Use Cannabis on Ballot in North Dakota
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — NCAA Removes Cannabis from List of Banned Substances
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Cronos Group Inc. to Reconvene Virtual 2024 Annual Meeting of Shareholders
From Cronos Group Inc.
Via GlobeNewswire
Cronos' New Cannabis Products To Help You Breeze Through Summer
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cronos Brand Spinach® Celebrates Summer with New Launches
From Cronos Group Inc.
Via GlobeNewswire
Cronos Group Inc. Announces Results of 2024 Annual Meeting of Shareholders
From Cronos Group Inc.
Via GlobeNewswire
Cronos Cannabis Co. Will Provide $51M To GrowCo Toward Facility Expansion Fund
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cronos Group Announces Expansion of GrowCo to Fuel Global Growth
From Cronos Group Inc.
Via GlobeNewswire
Japan Gathering Public Feedback on Proposed Marijuana Reforms
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Study Shows Prebedtime Marijuana Use Doesn’t Trigger Impairment
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Cronos Group Inc. to Speak at Bernstein's 40th Annual Strategic Decisions Conference
From Cronos Group Inc.
Via GlobeNewswire
Cronos Terminates Sale-Leaseback of Peace Naturals Campus
From Cronos Group Inc.
Via GlobeNewswire
420 with CNW — Poll Suggests Florida Cannabis Legalization Measure Will Narrowly Miss Voter Approval
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Cronos Group Reports 2024 First Quarter Results
From Cronos Group Inc.
Via GlobeNewswire
Canadian Marijuana Company Cronos Expands Into UK After Setting Up In Germany's Nascent Market
Via Benzinga
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.